Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial
2022 · Clinical Microbiology and Infection · 100 citations
https://doi.org/10.1016/j.cmi.2021.12.026
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
190
Citations
2
h-index
2
i10-index
Sanaa Alrehily is an academic researcher from Ministry of Health. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & COVID-19 and Mental Health. The author has an h-index of 2, co-authored 3 publications.
Click to start Chat